Christine Stabell Benn

@StabellBenn

Professor in Global Health, investigating the immune training effects of vaccines . Aiming to nuance the debate about vaccines. Views are my own.

Vrijeme pridruživanja: listopad 2018.

Tweetovi

Blokirali ste korisnika/cu @StabellBenn

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @StabellBenn

  1. Prikvačeni tweet

    My talk about "How vaccines train the immune system in ways no one expected" is online:

    Poništi
  2. proslijedio/la je Tweet
    4. velj

    This is highly problematic: Electronic patient records systems used by thousands of doctors were programmed to automatically suggest opioids at treatment, thanks to a secret deal between the software maker and a drug company via

    Poništi
  3. proslijedio/la je Tweet
    3. velj

    Can safety questions about the be answered after only 24 months?: Great analysis by for on safety concerns and challenges.

    Poništi
  4. proslijedio/la je Tweet
    31. sij

    In the past 40 years, Danish research has shown that the story of vaccines is not quite as simple as , national health authorities and others portray it.

    Poništi
  5. proslijedio/la je Tweet
    2. velj
    Odgovor korisnicima i sljedećem broju korisnika:
    Poništi
  6. proslijedio/la je Tweet
    1. velj
    Odgovor korisnicima i sljedećem broju korisnika:

    That's a very good point. To me, one of the issue is that this is how pharmaceuticals are discussed--each has efficacy, side effects, pricing, etc.... Vaccines don't get this type of media treatment. They are just seen as an immediate good.

    Poništi
  7. proslijedio/la je Tweet
    1. velj
    Odgovor korisnicima i sljedećem broju korisnika:

    That's another way of looking at it, yes. Or it could be that both are happening simultaneously, with variance in different populations. Point is that we continue with this half a sandwich conversation. It's all peanut butter and no jelly. More honest talk about safety.

    Poništi
  8. 1. velj

    A story of potential interest for those concerned that interventions are developed based on intermediate outcomes. In this case, malaria protection may come at the price of higher overall mortality for girls.

    Poništi
  9. 1. velj
    Poništi
  10. proslijedio/la je Tweet
    1. velj

    Concise and clear summary of the story about the new malaria vaccine. and there are serious concerns being raised. Please confirm that you will address these. Trials should be done carefully and with consent of partipants.

    Poništi
  11. proslijedio/la je Tweet
    1. velj

    What the world needs: Malaria vaccine What the world does not need: Sexist medical systems that ignore girl child mortality rates. what's going on here?

    Poništi
  12. 31. sij

    It is a real risk is that the pilot study will find no increased female mortality due to these shortcomings, and therefore the vaccine will be approved for use in Africa even though it has harmful non-specific effects for girls. What will do to repair this situation?

    Prikaži ovu nit
    Poništi
  13. 31. sij

    The lack of participant registration, the potentially flawed death registration, the short follow-up and the low coverage all act in the same direction: making it difficult to document increased mortality among vaccinated girls, even if it should exist.

    Prikaži ovu nit
    Poništi
  14. 31. sij

    Adding to the problems, the first reports from the pilot study indicate that vaccine coverage is very low. So far in Malawi, the first dose reached about half of the children targeted, further diminishing the power to detect any mortality difference. ?

    Prikaži ovu nit
    Poništi
  15. 31. sij

    This means that most study children will only have had 1-3 of the 4 vaccines before a decision is made. As we point out, the negative vaccine effects became worse with additional doses, e.g. girls had more than 3-fold higher mortality after more vaccines.

    Prikaži ovu nit
    Poništi
  16. 31. sij

    The latest development is worrying: The pilot study was to have 720,000 children and last 4 years to capture a negative effect of the vaccine on girls’ mortality. But now, after pressure from , WHO decided to make a decision already after 2 years.

    Prikaži ovu nit
    Poništi
  17. 31. sij

    Deaths are difficult to keep track of. E.g. in Malawi there are no official death registries, hospital staff have not routinely registered hospital deaths, and to report deaths outside hospital the study relies on town chiefs, many being illiterate.

    Prikaži ovu nit
    Poništi
  18. 31. sij

    Is this then being done? Is it ensured that every participant and each death in this pilot study is registered? Unfortunately no. The vaccine is added to the vaccination program in some regions, but not in others. There is no individual registration of participants.

    Prikaži ovu nit
    Poništi
  19. 31. sij

    The only justification for a large pilot implementation study would be if the increased mortality in girls was a chance finding. The probability is <0.001. But it could be. But given this situation, it is indispensable to follow children very closely for mortality.

    Prikaži ovu nit
    Poništi
  20. 31. sij

    However, all available evidence suggests that if you are a girl, the vaccine may reduce your risk of malaria, but this benefit is offset by a negative non-specific effect (also seen for other non-live vaccines) that leads to increased OVERALL mortality.

    Prikaži ovu nit
    Poništi
  21. 31. sij

    The pilot study was launched in Malawi in April 2019, Ghana and Kenya followed. stated that "The malaria vaccine has the potential to save tens of thousands of children’s lives”. Excited media praised the possibility to combat malaria.

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·